Tagesvorschau: Marktgeschehen am 25. Juli
Eine wahren Datenflut erwartet uns am DonnerstagHeute stehen zahlreiche Unternehmensberichte an, darunter die Halbjahreszahlen von Audi, Hermes, Roche und AstraZeneca.…
71,750€
1,06%
Echtzeit-Aktienkurs Astrazeneca PLC (Spons. ADRs)
Bid:
Ask:
Nachrichten zur Astrazeneca PLC (Spons. ADRs) Aktie
Is AstraZeneca (AZN) a Portfolio Must-Have Pre-Q2 Earnings?
Sales of AstraZenecas (AZN) key drugs like Imfinzi and Farxiga are expected to have been boosted by approvals in new…
AstraZeneca Stock: Upgrading From Hold To Buy Ahead Of Q2 2024 Earnings
…
AstraZeneca (AZN) Stock Rises 18% YTD: Should You Buy?
AstraZenecas (AZN) key drugs like Lynparza, Tagrisso, Imfinzi, Ultomiris and Farxiga should drive sales. Its pipeline is huge with several…
Acquisition of Amolyt Pharma completed
15 July 2024
Acquisition of Amolyt Pharma completed
AstraZeneca today announced the successful completion of theacquisition (https://www.astrazeneca.com/media-centre/press-releases/2024/astrazeneca-to-acquire-amolyt.html) of Amolyt Pharma, a clinical-stage biotechnology company focused…